Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.44% | -74.19% | -0.86% | -19.63% | 0.32% |
| Total Depreciation and Amortization | -0.48% | 15.62% | -0.85% | -5.89% | 0.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.48% | 381.94% | 0.86% | -160.33% | 0.31% |
| Change in Net Operating Assets | -0.60% | 150.04% | 0.82% | -117.98% | 0.31% |
| Cash from Operations | -0.48% | 81.51% | -0.86% | -63.29% | 0.31% |
| Capital Expenditure | 0.48% | -579.92% | 0.82% | 71.79% | -0.30% |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | 0.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 99.18% | 0.87% | -160.71% | -0.32% |
| Cash from Investing | 0.48% | 24.37% | 0.86% | -49.61% | -0.31% |
| Total Debt Issued | 0.00% | -7.57% | 0.00% | 42.19% | 0.00% |
| Total Debt Repaid | 0.00% | 11.91% | 0.00% | -49.65% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 98.95% | 0.86% | 25.65% | -0.31% |
| Other Financing Activities | 0.00% | -454.38% | 0.00% | 88.06% | 0.00% |
| Cash from Financing | 0.48% | 82.43% | 0.85% | 26.93% | -0.32% |
| Foreign Exchange rate Adjustments | -0.86% | 11,500.00% | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.48% | 157.75% | 0.86% | -650.61% | 0.32% |